Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vascular regulation of antitumor immunity
Lance L. Munn, Rakesh K. Jain
Science (2019) Vol. 365, Iss. 6453, pp. 544-545
Open Access | Times Cited: 166

Showing 1-25 of 166 citing articles:

Physical traits of cancer
Hadi T. Nia, Lance L. Munn, Rakesh K. Jain
Science (2020) Vol. 370, Iss. 6516
Open Access | Times Cited: 585
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin, Horacio Cabral, Triantafyllos Stylianopoulos, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 4, pp. 251-266
Open Access | Times Cited: 544
Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response
Tong‐Ming Fu, Lei-Jie Dai, Song‐Yang Wu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 322
Combining microenvironment normalization strategies to improve cancer immunotherapy
Fotios Mpekris, Chrysovalantis Voutouri, James W. Baish, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 7, pp. 3728-3737
Open Access | Times Cited: 233
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy
Bin Wang, Qin Zhao, Yuyu Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 223
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 214
Neoadjuvant immunotherapy with nivolumab and ipilimumab induces major pathological responses in patients with head and neck squamous cell carcinoma
Joris L. Vos, Joris B.W. Elbers, Oscar Krijgsman, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 209
Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities
Stephen P. Hack, Andrew X. Zhu, Yulei Wang
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 204
Resistance to PD-1/PD-L1 blockade cancer immunotherapy: mechanisms, predictive factors, and future perspectives
Jin‐Yu Sun, Dengke Zhang, Songquan Wu, et al.
Biomarker Research (2020) Vol. 8, Iss. 1
Open Access | Times Cited: 183
2-Oxoglutarate-dependent dioxygenases in cancer
Julie-Aurore Losman, Peppi Koivunen, William G. Kaelin
Nature reviews. Cancer (2020) Vol. 20, Iss. 12, pp. 710-726
Closed Access | Times Cited: 175
Bioengineered nanogels for cancer immunotherapy
Xianbin Ma, Shu‐Jin Li, Yuantong Liu, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5136-5174
Closed Access | Times Cited: 131
LRG1: an emerging player in disease pathogenesis
Carlotta Camilli, Alexandra E. Hoeh, Giulia De Rossi, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 114
Coagulome and the tumor microenvironment: an actionable interplay
Antoine Galmiche, Janusz Rak, Lubka T. Roumenina, et al.
Trends in cancer (2022) Vol. 8, Iss. 5, pp. 369-383
Open Access | Times Cited: 74
STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy
Lihong Wang-Bishop, Blaise R. Kimmel, Verra M. Ngwa, et al.
Science Immunology (2023) Vol. 8, Iss. 83
Open Access | Times Cited: 56
Vessel co-option in glioblastoma: emerging insights and opportunities
Giorgio Seano, Rakesh K. Jain
Angiogenesis (2019) Vol. 23, Iss. 1, pp. 9-16
Open Access | Times Cited: 121
Vessel co-option and resistance to anti-angiogenic therapy
Elizabeth A. Kuczynski, Andrew R. Reynolds
Angiogenesis (2019) Vol. 23, Iss. 1, pp. 55-74
Open Access | Times Cited: 106
Dysregulation of Glutamate Transport Enhances Treg Function That Promotes VEGF Blockade Resistance in Glioblastoma
Yu Long, Haipeng Tao, Aida Karachi, et al.
Cancer Research (2019) Vol. 80, Iss. 3, pp. 499-509
Open Access | Times Cited: 97
Normalizing the Microenvironment Overcomes Vessel Compression and Resistance to Nano‐immunotherapy in Breast Cancer Lung Metastasis
Fotios Mpekris, Myrofora Panagi, Chrysovalantis Voutouri, et al.
Advanced Science (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 88
Integrating tumor hypoxic stress in novel and more adaptable strategies for cancer immunotherapy
Raefa Abou Khouzam, Goutham Hassan Venkatesh, Rania F. Zaarour, et al.
Seminars in Cancer Biology (2020) Vol. 65, pp. 140-154
Open Access | Times Cited: 84
A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment
Zuzana Saidak, Simon Soudet, Marine Lottin, et al.
Cancer Immunology Immunotherapy (2020) Vol. 70, Iss. 4, pp. 923-933
Closed Access | Times Cited: 83
Vascular disrupting agents in cancer therapy
Ryszard Smolarczyk, Justyna Czapla, Magdalena Jarosz‐Biej, et al.
European Journal of Pharmacology (2020) Vol. 891, pp. 173692-173692
Closed Access | Times Cited: 75
Overcoming microenvironmental resistance to PD-1 blockade in genetically engineered lung cancer models
Amaia Martinez‐Usatorre, Ece Kadioglu, Gaël Boivin, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 606
Open Access | Times Cited: 73
Vascular Normalization: A New Window Opened for Cancer Therapies
Ting Yang, Hongqi Xiao, Xiaoxia Liu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 73
Development and aging of the lymphatic vascular system
Alejandra González‐Loyola, Tatiana V. Petrova
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 63-78
Open Access | Times Cited: 71
Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models
Myrofora Panagi, Fotios Mpekris, Pengwen Chen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top